Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sotera Health CoSHC · Entity 3869 | Sr. Vice President, CFO | August 05, 2026 | August 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sotera Health Co
Report date August 05, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par value per shareSEC Table I · non-derivative | Direct | 217,304 |
Reported balance
After 2026-08-05 transaction · row 1
1 source rowRow 1 · 2026-08-05 · Tax withholding · Disposed 11,316 · Balance 217,304 F1: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 25,657 Restricted Stock Units ("RSUs"), which represents 33% of the RSU awards granted to the Reporting Person on August 7, 2023. These awards were granted pursuant to the terms of RSU agreements under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $14.59 · Expires 2034-03-04 | Direct | 81,676 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 81,676 F2: No transaction is being reported on this line. Reported on a previously filed Form 4. F3: These options were granted on March 4, 2024, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing on March 2, 2025, subject to the Reporting Person's continued service through each such date. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $16.89 · Expires 2033-08-07 | Direct | 33,640 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 33,640 F2: No transaction is being reported on this line. Reported on a previously filed Form 4. F4: These options were granted on August 7, 2023, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing August 5, 2024, subject to the Reporting Person's continued service through each such date. |
| Performance RSUsSEC Table II · derivative / convertible security | Direct | 11,958 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 11,958 F2: No transaction is being reported on this line. Reported on a previously filed Form 4. F5: These securities consist of the remaining additional performance-based RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each additional RSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. These RSUs vest in equal installments on March 3, 2027 and March 3, 2028, subject to performance. |
| Performance RSUsSEC Table II · derivative / convertible security | Direct | 29,678 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 29,678 F2: No transaction is being reported on this line. Reported on a previously filed Form 4. F6: These securities consist of the maximum number of additional performance-based RSUs that were granted on March 2, 2026, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each additional RSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. The additional RSUs generally vest annually in 60%, 20% and 20% installments, respectively, commencing March 2027, subject to performance. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 25,657 Restricted Stock Units ("RSUs"), which represents 33% of the RSU awards granted to the Reporting Person on August 7, 2023. These awards were granted pursuant to the terms of RSU agreements under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions.
F2: No transaction is being reported on this line. Reported on a previously filed Form 4.
F3: These options were granted on March 4, 2024, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing on March 2, 2025, subject to the Reporting Person's continued service through each such date.
F4: These options were granted on August 7, 2023, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing August 5, 2024, subject to the Reporting Person's continued service through each such date.
F5: These securities consist of the remaining additional performance-based RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each additional RSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. These RSUs vest in equal installments on March 3, 2027 and March 3, 2028, subject to performance.
F6: These securities consist of the maximum number of additional performance-based RSUs that were granted on March 2, 2026, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each additional RSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. The additional RSUs generally vest annually in 60%, 20% and 20% installments, respectively, commencing March 2027, subject to performance.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 05, 2026 Filed Aug 7, 2026 20:16 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock, $0.01 par value per share | 11,316 | $17.98 | $203,461.68 |
DisclosureSEC source: 0001193125-26-340288 · ownership.xml · nonDerivative · entry 1 Lyons Jonathan M. · CIK 0001983511 · Sr. Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,304 F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 25,657 Restricted Stock Units ("RSUs"), which represents 33% of the RSU awards granted to the Reporting Person on August 7, 2023. These awards were granted pursuant to the terms of RSU agreements under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:54 UTC | Sotera Health Co SHC · Entity 3869 | GrantPerformance RSUs · Derivative | 29,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-092207 · ownership.xml · derivative · entry 7 Lyons Jonathan M. · CIK 0001983511 · Sr. Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,678 Underlying: Common Stock · 29,678 shares Expires not disclosed F7 · derivative.exercise_price: These securites consist of the maximum number of additional performance-based RSUs that were granted on March 2, 2026, prusuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each additional RSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related conditions. The additional RSUs generally vest annually in 60%, 20% and 20% installments, respectfully, commencing March 2027, subject to performance. F7 · shares: These securites consist of the maximum number of additional performance-based RSUs that were granted on March 2, 2026, prusuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each additional RSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related conditions. The additional RSUs generally vest annually in 60%, 20% and 20% installments, respectfully, commencing March 2027, subject to performance. F7 · derivative.exercise_date: These securites consist of the maximum number of additional performance-based RSUs that were granted on March 2, 2026, prusuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each additional RSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related conditions. The additional RSUs generally vest annually in 60%, 20% and 20% installments, respectfully, commencing March 2027, subject to performance. F7 · derivative.expiration_date: These securites consist of the maximum number of additional performance-based RSUs that were granted on March 2, 2026, prusuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each additional RSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related conditions. The additional RSUs generally vest annually in 60%, 20% and 20% installments, respectfully, commencing March 2027, subject to performance. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:54 UTC | Sotera Health Co SHC · Entity 3869 | Exercise / conversionPerformance RSUs · Derivative | 17,937 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-092207 · ownership.xml · derivative · entry 6 Lyons Jonathan M. · CIK 0001983511 · Sr. Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,958 Underlying: Common Stock · 17,937 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These securities consist of additional performance-based RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU Agreement under the 2020 Incentive Plan. Each additional RSU represented the Reporting Person's right to receive one share of Common Stock subject to stock price-related performance conditions. Regarding the additional RSUs, the Reporting Person vested in 17,937 shares of Common Stock on March 2, 2026. The remaining additional RSUs under the award vest annually in equal installments in March 2027 and March 2028, subject to performance. F3 · price: These securities consist of additional performance-based RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU Agreement under the 2020 Incentive Plan. Each additional RSU represented the Reporting Person's right to receive one share of Common Stock subject to stock price-related performance conditions. Regarding the additional RSUs, the Reporting Person vested in 17,937 shares of Common Stock on March 2, 2026. The remaining additional RSUs under the award vest annually in equal installments in March 2027 and March 2028, subject to performance. F3 · derivative.exercise_date: These securities consist of additional performance-based RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU Agreement under the 2020 Incentive Plan. Each additional RSU represented the Reporting Person's right to receive one share of Common Stock subject to stock price-related performance conditions. Regarding the additional RSUs, the Reporting Person vested in 17,937 shares of Common Stock on March 2, 2026. The remaining additional RSUs under the award vest annually in equal installments in March 2027 and March 2028, subject to performance. F3 · derivative.expiration_date: These securities consist of additional performance-based RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU Agreement under the 2020 Incentive Plan. Each additional RSU represented the Reporting Person's right to receive one share of Common Stock subject to stock price-related performance conditions. Regarding the additional RSUs, the Reporting Person vested in 17,937 shares of Common Stock on March 2, 2026. The remaining additional RSUs under the award vest annually in equal installments in March 2027 and March 2028, subject to performance. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:54 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock | 59,355 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-092207 · ownership.xml · nonDerivative · entry 5 Lyons Jonathan M. · CIK 0001983511 · Sr. Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,620 F6 · shares: These securities consist of RSUs that were granted on March 2, 2026, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 2027. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:54 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock | 8,240 | $15.91 | $131,098.40 |
DisclosureSEC source: 0001193125-26-092207 · ownership.xml · nonDerivative · entry 4 Lyons Jonathan M. · CIK 0001983511 · Sr. Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,265 F5 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 18,684 RSUs granted to the Reporting Person on March 3, 2025. This award was granted pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:54 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock | 23,988 | $15.91 | $381,649.08 |
DisclosureSEC source: 0001193125-26-092207 · ownership.xml · nonDerivative · entry 3 Lyons Jonathan M. · CIK 0001983511 · Sr. Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,505 F4 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 53,811 RSUs granted to the Reporting Person on March 3, 2025. This award was granted pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to recieve one share of Common Stock, subject to vesting conditions or performance, as applicable. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:54 UTC | Sotera Health Co SHC · Entity 3869 | Exercise / conversionCommon Stock | 17,937 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-092207 · ownership.xml · nonDerivative · entry 2 Lyons Jonathan M. · CIK 0001983511 · Sr. Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: A portion of the Reporting Person's March 3, 2025 additional performance-based RSUs vested on March 2, 2026 based upon the achievement of performance conditions. As a result, the Reporting Person received an additional 17,937 shares of Common Stock. F3 · shares: These securities consist of additional performance-based RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU Agreement under the 2020 Incentive Plan. Each additional RSU represented the Reporting Person's right to receive one share of Common Stock subject to stock price-related performance conditions. Regarding the additional RSUs, the Reporting Person vested in 17,937 shares of Common Stock on March 2, 2026. The remaining additional RSUs under the award vest annually in equal installments in March 2027 and March 2028, subject to performance. F3 · price: These securities consist of additional performance-based RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU Agreement under the 2020 Incentive Plan. Each additional RSU represented the Reporting Person's right to receive one share of Common Stock subject to stock price-related performance conditions. Regarding the additional RSUs, the Reporting Person vested in 17,937 shares of Common Stock on March 2, 2026. The remaining additional RSUs under the award vest annually in equal installments in March 2027 and March 2028, subject to performance. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:54 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") | 6,046 | $15.91 | $96,191.86 |
DisclosureSEC source: 0001193125-26-092207 · ownership.xml · nonDerivative · entry 1 Lyons Jonathan M. · CIK 0001983511 · Sr. Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,556 F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 13,708 Restricted Stock Units ("RSUs") granted to the Reporting Person on March 4, 2024. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. Read SEC document |
| August 05, 2025 Filed Aug 7, 2025 22:09 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") | 11,508 | $11.19 | $128,774.52 |
DisclosureSEC source: 0000950170-25-105286 · ownership.xml · nonDerivative · entry 1 Lyons Jonathan M. · CIK 0001983511 · Sr. Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,602 F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 25,655 Restricted Stock Units ("RSUs"), which represents 33% of the RSU award granted to the Reporting Person on August 7, 2023. These awards were granted pursuant to the terms of RSU agreements under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 01:36 UTC | Sotera Health Co SHC · Entity 3869 | GrantPerformance RSUs · Derivative | 29,895 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-032829 · ownership.xml · derivative · entry 4 Lyons Jonathan M. · CIK 0001983511 · Sr. Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,895 Underlying: Common Stock · 29,895 shares Expires not disclosed F5 · derivative.exercise_price: These securities consist of a maximum number of additional performance-based RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each additional RSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. The additional RSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026, subject to performance. F5 · shares: These securities consist of a maximum number of additional performance-based RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each additional RSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. The additional RSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026, subject to performance. F5 · derivative.exercise_date: These securities consist of a maximum number of additional performance-based RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each additional RSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. The additional RSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026, subject to performance. F5 · derivative.expiration_date: These securities consist of a maximum number of additional performance-based RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each additional RSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. The additional RSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026, subject to performance. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 01:36 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock | 37,369 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-032829 · ownership.xml · nonDerivative · entry 3 Lyons Jonathan M. · CIK 0001983511 · Sr. Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,110 F3 · shares: These securities consist of RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting condictions. The RSUs vest in two equal installments on each of March 3, 2026 and March 3, 2027, subject to the Reporting Person's continued service through each such date. F4 · balance_after: These securities consist of 175,887 RSUs and 25,223 shares of Common Stock. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 01:36 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock | 59,790 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-032829 · ownership.xml · nonDerivative · entry 2 Lyons Jonathan M. · CIK 0001983511 · Sr. Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,741 F2 · shares: These securities consist of RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026. Read SEC document |
| March 02, 2025 Filed Mar 5, 2025 01:36 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") | 6,481 | $12.47 | $80,818.07 |
DisclosureSEC source: 0000950170-25-032829 · ownership.xml · nonDerivative · entry 1 Lyons Jonathan M. · CIK 0001983511 · Sr. Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,951 F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 13,708 Restricted Stock Units ("RSUs"), which represents 33% of the RSU award granted to the Reporting Person on March 4, 2024. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:20 UTC | Sotera Health Co SHC · Entity 3869 | Tax withholdingCommon Stock, $0.01 par value per share ("Common Stock") | 7,659 | $14.22 | $108,910.98 |
DisclosureSEC source: 0000950170-24-092827 · ownership.xml · nonDerivative · entry 1 Lyons Jonathan M. · CIK 0001983511 · Sr. Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,432 F1 · shares: These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 25,655 Restricted Stock Units ("RSUs"), which represents 33% of the RSU awards granted to the Reporting Person on August 7, 2023. These awards were granted pursuant to the terms of RSU agreements under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. F2 · price: Represents the closing price of the Common Stock on August 5, 2024. F3 · balance_after: These securities consist of 92,436 RSUs and 17,996 shares of Common Stock. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:54 UTC | Sotera Health Co SHC · Entity 3869 | GrantStock Options · Derivative | 81,676 | $0.00 Strike: $14.59 | $0.00 |
DisclosureSEC source: 0000950170-24-027276 · ownership.xml · derivative · entry 2 Lyons Jonathan M. · CIK 0001983511 · Sr. Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,676 Underlying: Common Stock · 81,676 shares Expires 2034-03-04 F3 · derivative.exercise_date: These options were granted on March 4, 2024, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing March 2, 2025, subject to vesting conditions. F3 · balance_after: These options were granted on March 4, 2024, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing March 2, 2025, subject to vesting conditions. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:54 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock, $0.01 par value per share ("Common Stock") | 41,124 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-027276 · ownership.xml · nonDerivative · entry 1 Lyons Jonathan M. · CIK 0001983511 · Sr. Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,091 F1 · shares: These securities consist of Restricted Stock Units ("RSUs") that were granted on March 4, 2024, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs vest annually in three equal installments commencing March 2, 2025. F2 · balance_after: These securites consist of 118,091 RSUs. Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 22:32 UTC | Sotera Health Co SHC · Entity 3869 | GrantStock Options · Derivative | 33,640 | $0.00 Strike: $16.89 | $0.00 |
DisclosureSEC source: 0001209191-23-045237 · doc4.xml · derivative · entry 2 Lyons Jonathan M. · CIK 0001983511 · Sr. Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,640 Underlying: Common Stock · 33,640 shares Expires 2033-08-07 F2 · derivative.exercise_date: These options were granted on August 7, 2023, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing August 5, 2024, subject to the Reporting Person's continued service through each such date. Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 22:32 UTC | Sotera Health Co SHC · Entity 3869 | GrantCommon Stock, $0.01 par value per share (Common Stock) | 76,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-045237 · doc4.xml · nonDerivative · entry 1 Lyons Jonathan M. · CIK 0001983511 · Sr. Vice President, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,967 F1 · shares: These securities consist of Restricted Stock Units ("RSUs") that were granted on August 7, 2023, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs vest annually in three equal installments commencing on August 5, 2024, subject to the Reporting Person's continued service through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.